Melanocyte protein PMEL;gp100;pmel 17
CAT No: ta-017
Synonyms/Alias:Melanocyte protein Pmel 17 precursor (17-25); gp100(17-25)
gp100(17-25) is a synthetic peptide fragment derived from the human glycoprotein 100 (gp100), a melanocyte differentiation antigen frequently studied in the context of tumor immunology and antigen presentation. As a nonapeptide corresponding to amino acids 17 through 25 of the gp100 protein, it is recognized for its immunogenic properties and relevance in the study of T cell responses specific to melanoma-associated antigens. Researchers value this peptide for its well-characterized sequence and its capacity to serve as a defined epitope in immunological assays, making it a vital tool in both fundamental and translational studies focused on antigen processing, presentation, and immune recognition.
Epitope mapping: The gp100(17-25) peptide is extensively used in epitope mapping studies to identify and characterize T cell epitopes presented by major histocompatibility complex (MHC) molecules. By incorporating this sequence into in vitro assays, investigators can determine its binding affinity to specific HLA alleles, map T cell receptor (TCR) recognition patterns, and dissect the molecular interactions that underlie antigen specificity. This approach is particularly valuable in elucidating the determinants of immune recognition in melanoma and other pigment cell disorders, providing insights into the mechanisms governing antigen processing and presentation.
Immunological assay development: As a well-defined antigenic peptide, gp100(17-25) is frequently employed in the development and optimization of immunological assays, such as enzyme-linked immunospot (ELISPOT), intracellular cytokine staining, and tetramer-based flow cytometry. Its use enables researchers to quantify antigen-specific CD8+ T cell responses, evaluate immune repertoire diversity, and monitor functional activation of cytotoxic lymphocytes. These applications are essential in preclinical research, vaccine evaluation, and immune monitoring studies, where precise detection and quantification of antigen-specific responses are critical.
T cell functional studies: The peptide serves as a reliable reagent for stimulating and expanding gp100-specific cytotoxic T lymphocytes (CTLs) in vitro. By pulsing antigen-presenting cells with this defined epitope, scientists can assess T cell activation, proliferation, cytotoxicity, and cytokine production. Such functional assays are instrumental in understanding the dynamics of anti-tumor immune responses, investigating mechanisms of T cell tolerance or exhaustion, and optimizing protocols for adoptive T cell transfer experiments.
Antigen processing and presentation research: gp100(17-25) provides a model substrate for studying the intracellular pathways involved in antigen processing and peptide loading onto class I MHC molecules. By tracking the fate of this peptide in cell-based systems, researchers can dissect proteasomal cleavage, transporter associated with antigen processing (TAP) translocation, and peptide-MHC complex stability. These studies contribute to a deeper understanding of the molecular events that drive immune surveillance and the escape mechanisms employed by tumor cells.
Peptide-based screening platforms: In high-throughput screening and validation studies, this peptide can be incorporated into peptide libraries or multiplexed assay formats to evaluate the specificity and cross-reactivity of T cell receptors, monoclonal antibodies, or engineered immune receptors. Its defined sequence and immunological relevance make it a valuable control or target in the development of novel immunodiagnostic tools, peptide-based vaccines, and next-generation immunotherapies. By facilitating precise and reproducible screening, gp100(17-25) supports the advancement of both basic research and applied immunology.
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.